Prescribing #HighEfficacy drugs early in #MS disease course is strategy w/most favorable #CostBenefit ratio. Even more clear if clinical relapses are considered only tip of iceberg of MS activity. More&more studies show limited window of opportunity fo
1,090 followers
16,835 followers
1,164 followers
490 followers